Skip to main content

Table 1 Sociodemographic characteristics and medical history of the studied groups

From: Evaluation of beta-blocker effects on patients with traumatic brain injury: interventional double-blinded randomized controlled trial

 

Beta-blocker group (n = 20)

Control group (n = 20)

Test of significance

p-value

No

%

No

%

Age (years)

  

t

 

 Mean ± SD

43.2 ± 11.04

43.95 ± 11.7

0.208

0.836

 Range

22–61

22–61

BMI

  

t

 

 Mean ± SD

27.6 ± 4.1

27.9 ± 4.9

0.219

0.827

 Range

22.4–35.8

19.2–41.0

Sex

  

χ2

 

 Male

14

70.0

13

65.0

0.114

0.736

 Female

6

30.0

7

35.0

Medical history

Hypertension

  

χ2

 

  Yes

7

35.0

8

40.0

0.107

0.744

  No

13

65.0

12

60.0

DM

  

FE

 

  Yes

4

20.0

5

25.0

0.143

1.000

  No

16

80.0

15

75.0

CLD

  

FE

 

  Yes

2

10.0

1

5.0

0.360

1.000

  No

18

90.0

19

95.0

Cardiac

  

FE

 

  Yes

1

5.0

0

0.0

1.026

1.000

  No

19

95.0

20

100.0

Cause of trauma

  

χ2

 

 RTA

14

70.0

12

60.0

1.354

0.508

 FFH

3

15.0

6

30.0

 Fight

3

15.0

2

10.0

  1. Range (minimum–maximum)
  2. SD Standard deviation, BMI Body mass index, DM Diabetes millitus, CLD Cirrhotic liver disease, t Student t-test, FE Fisher’s exact test, χ2 chi-square test
  3. P > 0.05: non-significant